Washington, August 22 : For all those people who are suffering from the deadly skin cancer melanoma, the invention of a drug that can prolong lives, might bring some relief.
The drug, hailed as the first to prolong the lives of patients suffering from the deadly skin cancer, is a step closer to being made widely available.
Yervoy (ipilimumab) has been awarded a European licence, which means patients in the UK can access it, although it has not yet been approved for use on the NHS.